Intellectual Property

28/02/2023

How do we live in a bioeconomy? EuropaBio at the Swedish EU Council Presidency conference

23/02/2023

EuropaBio Response to Public Consultation on Horizon Europe – interim evaluation

17/02/2023

Inter-association letter to raise our concern about the proposed definition of “natural polymers” in the REACH restriction of microplastics

29/06/2021

A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property

We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.

07/05/2021

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge

2021_05_H_PR_Waiver of Intellectual Property Rights for COVID-19 Vaccines – EuropaBio’s Position

25/11/2020

How do we live in a bioeconomy? EuropaBio at the Swedish EU Council Presidency conference

EuropaBio Response to Public Consultation on Horizon Europe – interim evaluation

Inter-association letter to raise our concern about the proposed definition of “natural polymers” in the REACH restriction of microplastics

A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge

An EU IP Action Plan for strong industrial ecosystems